Stay updated on Clinical Trial: Avelumab Combo vs Doxorubicin in Ovarian Cancer
Sign up to get notified when there's something new on the Clinical Trial: Avelumab Combo vs Doxorubicin in Ovarian Cancer page.

Latest updates to the Clinical Trial: Avelumab Combo vs Doxorubicin in Ovarian Cancer page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedFooter revision updated to v3.6.3, replacing the previous v3.6.1 tag to reflect an update in the page version; the change does not modify study content.SummaryDifference0.0%

- Check21 days agoChange DetectedThe page displays Revision: v3.6.1, replacing Revision: v3.6.0, indicating a recent build update.SummaryDifference0.0%

- Check35 days agoChange DetectedAdded user-guidance sections for reading the study record and joining a study, and updated the recruitment status to indicate no current participant enrollment; a heading format adjustment and a software revision tag update were also applied.SummaryDifference0.1%

- Check43 days agoChange DetectedThe page shows a new revision tag (v3.5.5) replacing the previous v3.5.4, indicating a newer version of the page content.SummaryDifference0.0%

- Check57 days agoChange DetectedRevision tag updated from v3.5.3 to v3.5.4, signaling a minor update to the page’s version.SummaryDifference0.0%

- Check72 days agoChange DetectedTaoyuan, Taiwan, 333 was replaced with Taoyuan City, Taiwan, 333 in the locations section, clarifying the city designation for that site.SummaryDifference0.0%

Stay in the know with updates to Clinical Trial: Avelumab Combo vs Doxorubicin in Ovarian Cancer
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Avelumab Combo vs Doxorubicin in Ovarian Cancer page.